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Summary 
Recently, a severe combined immunodeficiency s ndrome with a deficiency of CD8 + periph- 
eral T cells and a TCR signal transduction defect in peripheral CD4 + T cells was associated 
with mutations in ZAP-70. Since TCR signaling is required in developmental decisions result- 
ing in mature CD4 (and CD8) T cells, the presence of peripheral CD4 + T cells expressing 
TCRs incapable of signaling in these patients is paradoxical. Here, we show that the TCRs on 
thymocytes, but not peripheral T cells, from a ZAP-70-deficient patient are capable of signal- 
ing. Moreover, the TCR on a thymocyte line derived from this patient can signal, and the ho- 
mologous kinase Syk is present at high levels and is tyrosine phosphorylated after TCR stimu- 
lation. Thus, Syk may compensate for the loss of ZAP-70 and account for the thymic selection 
of at least a subset o fT  cells (CD4 +) in ZAP-70-deficient patients. 
T he severe combined immunodeficiency syndrome (SCID) 1 comprises a group of heterogeneous disorders 
affecting the functional activity of both T and B lympho- 
cytes (1). Phenotypically, infants with SCID can have ei- 
ther a marked deficiency in circulating lymphocytes or 
normal numbers of T and B ceils whose function is abnor- 
mal. T ceil immunity abnormalities in SCID have been as- 
sociated with an absence o fT  cell differentiation (2), failure 
to produce IL-2 (3), and mutations in the genes encoding 
the ~/chain of the IL-2 receptor (4, 5) or the CD3 ~/sub- 
unit of the TCR (6). Recent studies have also described 
defects in the ZAP-70 protein tyrosine kinase (PTK), 
which is involved in signal transduction through the TCR 
(7-9). 
Stimulation of TCRs on T lymphocytes leads to the ty- 
rosine phosphorylation of specific intracellular substrates 
and the subsequent rapid increase in cytoplasmic free Ca z+ 
levels ([Ca2+]i) (10-14). Since the component chains of the 
TCR do not contain an intrinsic kinase domain, signal 
transduction must occur via association of these receptors 
with intracellular protein kinases (PTKs). Two PTK fami- 
1Abbreviations u ed in this paper: [Ca2+]i, cytoplasmic free Ca 2+ levels; 
HTLV, human T tymphotropic v rus; PLC, phospholipase C; PTK, pro- 
tein tryosine kinase; SCID, severe combined immunodeficiency syn- 
drome. 
lies have been shown to interact with the TCR.  Members 
of the Src family of PTKs, Fyn and Lck, have been impli- 
cated in T lymphocyte signal transduction and in T cell dif- 
ferentiation (13, 14). Fyn has been coimmunoprecipitated 
with the TCR (15) and inactivation ofthefyn gene impairs 
signal transduction i  mature thymocytes (16, 17). In a T 
cell line (18) and cytolytic T cell clone (19), Lck has been 
shown to be required for the induction of tyrosine phos- 
phoproteins, including the TCR CD3 and ~ chains. More- 
over, Lck-deficient mice exhibit a profound failure of early 
T cell development with few thymocytes and circulating T
cells that exhibit an impaired response to TCR stimuli (20). 
A second family of PTKs, consisting of ZAP-70 and Syk, 
have also been implicated in TCR-mediated signaling. In 
T cell lines, ZAP-70 and Syk are recruited to the phosphor- 
ylated CD3 and ~ subunits, where they are in turn tyrosine 
phosphorylated after TCR stimulation (21, 22). The failure 
of the recruitment of ZAP-70 to the TCR in an Lck-defi- 
cient T cell line suggests that it plays a role downstream of 
Lck (23). It was hypothesized, therefore, that the TCR 
may interact with members of these two families of PTKs 
sequentially (24). In this model, an Src family member 
would first phosphorylate yrosine residues contained in the 
and CD3 chains. Only then would ZAP-70 and/or Syk 
be recruited to the receptor complex via an interaction in- 
volving both of their SH2 domains with the phosphory- 
lated receptor chains. Once recruited to the receptor, 
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ZAP-70 and/or Syk can interact with Src family PTKs, re- 
suiting in a synergistic increase in PTK activity. 
ZAP-70 and Syk are structurally homologous, having 
two tandemly arranged SH2 domains and a COOH-termi -  
hal kinase domain (25, 26). ZAP-70 protein is expressed in 
T ceils and NK cells (26). It is also expressed in thymocytes 
at levels comparable to those found in peripheral CD4 + 
and CD8 + T cells (22). A role for ZAP-70 has been estab- 
lished in T cells (see below). Syk has been most clearly im- 
plicated in B cell mlg, as well as in mast cell Fc~RI signal 
transduction (27-30). After mlg or Fc~RI stimulation, Syk 
associates with the tyrosine-phosphorylated, non-ligand- 
binding chains of  both of  these receptors. Genetic evidence 
for the requisite function of Syk in mlg signal transduction 
function has been obtained in a chicken B cell line (30). 
The function of  Syk in T cells is not as clear, however. Syk 
protein is present at higher levels in thymocytes than pe- 
ripheral T cells, but the level of  Syk in peripheral T cells is 
only ~1/12-1 /15  of the level in B cells (22). In a T cell 
line expressing relatively high levels of  Syk, its association 
with the TCR and its tyrosine phosphorylation after recep- 
tor stimulation has been observed (31). Although some data 
suggest hat Syk can interact with the TCR independently 
of  Lck involvement and TCR engagement (31), this is not 
consistent with our published and more recent observations 
(22) (Chu, D., N. van Oers, and A. Weiss, unpublished 
data). 
Three recent studies have provided evidence that the ab- 
sence of ZAP-70 protein, which results from inherited mu- 
tations, leads to a form of  SCID (7-9). This syndrome is 
characterized by the absence of peripheral CD8 + T cells 
and a failure of  peripheral CD4 + T cells to signal normally 
through the TCR.  Since T cell differentiation and thymic 
selection appear to require TCR-mediated signaling, the 
emergence of  CD4 + T cells with TCRs  that cannot signal 
requires explanation. Here, we show that thymocytes from 
a ZAP-70-deficient patient can indeed signal through the 
TCR.  This is in marked contrast o the patient's peripheral 
T cells, which fail to respond to TCR stimuli. Using a hu- 
man T lymphotropic virus (HTLV-1)-transformed thy- 
mocyte line from this patient, we provide evidence that 
Syk may compensate for the loss of ZAP-70 in the thymus. 
These results emphasize the critical but perhaps redundant 
role for this family of  PTKs in T cell differentiation and se- 
lection. 
Materials and Methods 
Cells and Antibodies. PBMCs were isolated by density gradi- 
ent centrifugation from the patient and normal volunteers. A thy- 
mic biopsy was obtained from the patient after informed consent 
from a parent. A portion of normal thymus was obtained from a 
patient undergoing cardiac surgery. Single cell suspensions from 
the thymus were obtained by density gradient centrifugation. 
HTLV-1 transformation fthymocytes from the patient and from 
an immunologically normal individual undergoing cardiac sur- 
gery was performed as described (32). The HTLV-1 lines were 
maintained in RPMI 1649 medium supplemented with antibiot- 
ics, glutamine, FBS (10%), and IL-2 (20 U/ml). The phenotype 
of the lines was similar; they each expressed the TCR-c~/[3 (no 
TCR-8 was detected), CD4, and CD25, but they were CD8 de- 
ficient. 
The following mAbs were used in these studies: anti-Leu4 
(anti-CD3), antMx/[3 (WT31), and biotin derivatives (Becton 
Dickinson & Co., Mountain View, CA); anti-Leu3-biotin (anti- 
CD4; Becton Dickinson); 4G10 (antiphosphotyrosine) and anti- 
phospholipase-~/1 (anti-PLC-',/l) (Upstate Biologicals, Inc., Lake 
Placid, NY); and anti-TCR-B (T-Cell Diagnostics, Wobum, 
MA); anti-Lck (a kind gift from Dr. J. Bolen); anti-CD3 
(DAKO, Santa Barbara, CA); a mix ofmAbs G3/B2, anti-TCR-~ 
(33); and 2F3, anti-ZAP-70 (23). Rabbit heterosera used in- 
cluded: anti-ZAP-70 (26); anti-Fyn (a kind gift from Dr. J. 
Bolen, Bristol-Myers Squibb Pharmaceutical Research Institute, 
Princeton, NJ); anti-Syk (a kind gift from Dr. A. DeFranco, Uni- 
versity of California, San Francisco, CA); anti-TCR-~ (a kind 
gift from Dr. A. Weissman, National Institutes of Health, Be- 
thesda, MD); and anti-FcR',/ (a kind gift from Dr. J. P. Kinet, 
National Institutes of Health, Bethesda, MD). 
Flow Cytometric Analysis of Immunofluorescent Staining of PBMC 
and Thymocytes. Standard direct immunofluorescent methods 
were used to double stain for CD4 and CD8 expression on 
PBMC and thymocytes using antibodies from Coulter Corp. 
(Hialeah, FL). The cells were analyzed on an Epics Profile I flow 
cytometer (Coulter). 
Changes in [Ca2+]i. After the loading of PBMCs or thy- 
mocytes with indo-1 (Molecular Probes, Eugene, OR) (1 p,g/ 
ml), changes in [Ca2+]i in response to Leu 4 mAb (anti-Cl)3) 
were monitored in a spectrofluorimeter (F4010; Hitachi, Tokyo, 
Japan) and calculated as previously described (34). Changes m 
[Ca2+]i in indo-l-loaded, HTLV-l-transformed thymocyte lines 
were monitored in a SPEX spectrofluorimeter at 37~ according 
to previously published methods (9). Cells were stimulated with 
biotinylated anti-Leu4 mAb (2 ~zg/ml) followed by the addition 
ofstreptavidin (10 p,g/ml; Calbiochem, LaJolla, CA). 
lmmunoprecipitation and Western Blot Analyses. Methods are iden- 
tical with those previously described in detail (18, 22, 23), with 
the exception that in some experiments enzyme-linked chemolu- 
minescence (ECL) was used to detect proteins by Western blot- 
ting. Cells were stimulated in PBS at 37~ at a concentration of
108 cells per ml with biotinylated anti-Leu4 mAb and streptavi- 
din. In some experiments, biotinylated anti-Leu3 mAb was also 
included. Cells were lysed in a buffer containing 1% NP-4{}. 
Whole cell lysates from 1-2 X 106 unstimulated or stintulated 
cells were diluted in SDS before analysis by Western blotting. For 
immunoprecipitations, ly ates derived from 1-5 X 10 v cells were 
used. 
Northern Blot Analysis. Whole cell RNA was obtained using 
RNAsol (Teltest, Inc., Friendswood, TX). 30 b~g of RNA was 
electrophoresed in a I% agarose gel and transferred to nylon 
membranes. Duplicate filters were hybridized with either a full- 
length ZAP-70 cDNA probe or a ~-actin probe that had been ra- 
diolabeled with 32p (26). Washed blots were assessed by auto- 
radiography. 
Results 
Phenotype of Peripheral Blood T Lymphocytes and Thy- 
mocytes. The patient was a 4 1/2-too-old white male with 
a 2-mo history of  multiple infections and chronic diarrhea. 
A first child, he was the product of  a consanguineous rela- 
tionship. Initial evaluation revealed panhypogammaglobu- 
linemia and normal numbers of  circulating lymphocytes. 
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Figure 1. Deficiency ofCD8 + T cells in the peripheral b ood and thy- 
mus of a patient with SCID. PBMC (A) and thymocytes (B) were ob- 
tained and stained with anti-CD4 (phycoerythrin) a d anti-CD8 (FITC) 
mAb, and they were analyzed by flow cytometry. 
Examination of  peripheral blood T cells revealed adequate 
numbers o fCD4 + T cells but a marked paucity o fCD8 + T 
cells (Fig. 1 A); very few CD3 § CD8 + cells could be de- 
tected (<1%). Approximately 40% of peripheral blood 
MNC were CD19 + B cells. T cell proliferative responses 
and IL-2 production to a variety of  stimuli (phytohemag- 
glutinin, anti-CD3, anti-CD2, anti-TCR) were virtually 
absent. In contrast, the combination ofphorbol  ester/iono- 
mycin triggered a normal, IL-2-dependent proliferative re- 
sponse (Mazer, B.M., A. Hayward, and E. W. Gelfand, 
manuscript in preparation). 
At ~6 mo of age, a thymus biopsy was performed, re- 
vealing essentially normal architecture and the presence of 
Hassall's corpuscles. Single-cell preparations were analyzed 
(Fig. 1 B). The majority of  thymic cells were doubly 
stained for CD4 and CD8, ~-'9% were single CD4 +, and 
few if any CD8 + single positive were detected. 
Signaling through the TCR Mediates Changes in [Ca2+]i in 
Thymocytes, but not in Peripheral T Cells in this Patient. 
The immunologic studies suggested that this patient's 
CD4 + peripheral blood T cells might have impaired signal 
transduction function through the TCR.  Changes in 
[Ca2+]i after TCR. stimulation with an anti-CD3 mAb 
were therefore xamined by fluorimetry. After stimulation 
with anti-CD3 mAb, a rapid and sustained increase in 
[Ca2+]i was observed in T cells from a normal individual's 
PBMCs (Fig. 2 A). In contrast, no changes in [Ca2+]i were 
observed in the patient's PBMCs (Fig. 2 B). Similarly, un- 
like the responses observed in cells from normal individu- 
als, stimulation of  this patient's PBMCs with anti-CD2 
mAbs or phytohemagglutinin also failed to induce increases 
in [Ca2+]i (data not shown). However, addition of  alumi- 
num fluoride to the patient's cells, which mobilizes [Ca2+]i 
through mechanisms involving guanine nucleotide-bind- 
ing proteins, induced a rapid and sustained increase in 
[Ca2+]i (data not shown). This latter result suggests that the 
phosphatidylinositol signal transduction pathway, which 
regulates increases in [Ca2+]i nduced by the TCR., albeit 
through a distinct PLC, is intact in the patient's cells. Col- 
lectively, these observations demonstrate that the TCRs  
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Figure 2. The TCP, on the thymocytes but not on the peripheral b ood 
T cells can induce increases in [Ca2+]i . Indo-l-loaded PBMCs from a 
normal individual (A), PBMCs from the patient (B), thymocytes from a 
normal individual (C), or thymocytes from the patient (D) were stimu- 
lated with anti-CD3 mAb as indicated, and changes in [Ca2+]i were mon- 
itored by fluorimetry over time. 
expressed by the CD4 + T cells in this patient were unable 
to couple to TCR-regulated mechanisms responsible for 
increases in [Ca>]i. 
In view of  the paradoxical presence of CD4 cells with 
impaired TCR signal transduction function in the periph- 
eral blood of  this patient, the signal transduction function 
of  TCRs on the thymocytes from this patient was of  great 
interest. In contrast o the PBMCs from this patient, addi- 
tion of  anti-CD3 antibody to thymocytes i olated from the 
biopsy specimen from this patient resulted in a rapid and 
sustained increase in [Ca2+]i (Fig. 2 D). This increase in 
[Ca2+]i was similar in magnitude to the changes observed in 
thymocytes i olated from a normal individual (Fig. 2 C). 
Indeed, in additional experiments using flow cytometry to 
monitor calcium changes in individual cells, >80% of  the 
patient's thymocytes responded to the anti-CD3 mAb. 
Since the patient's thymocyte population was predomi- 
nantly composed o fCD4+/CD8 + (double-positive) imma- 
ture thyrnocytes (86%), these studies uggest that TCRs  ex- 
pressed on these immature double positive thymocytes 
were able to mediate early signal transduction events and 
increases in [Ca2+]i . 
ZAP-70 is Deficient in the Patient's PBMCs and in a 
Thymic Line Derived from the Patient. To define the mo-  
lecular basis for the TCFL signal transduction defect result- 
ing in differences in the signaling capacity of  this patient's 
PBMCs and thymocytes, we analyzed several PTKs impli- 
cated in TCR signaling. As shown in Fig. 3 A, normal ev- 
els of  Lck were detected in whole-cell ysates of  PBMCs 
from this patient, but no ZAP-70 protein was detected by 
Western blotting using an mAb directed against he NH2- 
terminal region encompassing the SH2 domains of  ZAP-70. 
To define the molecular basis for the failure of  this pa- 
tient's peripheral blood CD4 + cells to express ZAP-70 pro- 
tein, and to understand the differential signaling capacity of  
TCR.s in the thymus and PBMCs, an HTLV- l - t rans-  
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Figure 3. Absence ofdetectable 
ZAP-70 protein in the patient's 
peripheral blood T cells and in 
an HTLV-l-transformed thy- 
mocyte derived from the patient. 
Whole-cell ysates from PBMCs 
(A) or from HTLV-l-trans- 
formed lines derived from thy- 
mocytes (B) isolated from the 
patient (Pt) or from immunolog- 
ically normal individuals (C) 
were probed by Western blot 
analysis for the indicated pro- 
teins. Equivalent numbers of 
cells were used in each of these 
experiments. 
formed polyclonal cell line was derived from the thy- 
mocytes of  this patient as well as from the thymocytes of  an 
immunologically normal individual undergoing cardiac 
surgery. Like the patient's peripheral blood CD4 + T cells, 
the patient's CD4 + thymocyte line also failed to express 
ZAP-70 protein as assessed by Western blot analysis (Fig. 3 
B). This is in marked contrast o the ZAP-70 protein easily 
detected in lysates from the control thymocyte line. The 
patient's HTLV-1 thymocyte line expressed Lck and TCR-~ 
(Fig. 3 B), as well as CD4, Fyn, PLC-~/1, and CD3~ (data 
not shown). Despite the somewhat reduced levels of TCR-~, 
the TCR level on the plasma membrane of the patient's 
line was comparable to that of  the control line. Interest- 
ingly, the patient's HTLV-1 line expressed higher levels of  
Syk when compared to the control line. This was verified 
in separate xperiments using independently derived anti- 
Syk rabbit heterosera. We were unable to analyze levels of  
Syk protein in the peripheral blood T cells from the patient 
since limited quantities of  peripheral blood were available 
and Syk is expressed at high levels in monocytes and B 
cells, but only at very low levels in normal T cells. 
The failure of  this patient's PBMCs to mediate increases 
in [Ca2+]i, together with the deficiency in ZAP-70 protein, 
is consistent with recent reports of  patients with a similar 
peripheral blood T cell phenotype and signal transduction 
defect (7, 9). Previous studies (7-9) demonstrated muta- 
tions in the coding sequence of the ZAP-70 kinase domain 
in several independent families. In an effort to further de- 
fine the molecular basis for the failure of  the patient's T 
cells to express ZAP-70 protein, Northern blots were pre- 
pared with whole-cell RNA isolated from the patient and 
control thymocyte lines. In contrast o previous reports of  
ZAP-70-deficient patients, no ZAP-70 RNA could be de- 
tected in the thymocyte line derived from the patient (Fig. 
4). The consanguinity present in this family is likely to have 
contributed to this defect resulting from the homozygous 
inheritance of  two alleles of  ZAP-70 that are transcription- 
ally silent. Further molecular analysis of  this patient's ZAP- 
Figure 4. The patient's thymocyte 
line fails to express ZAP-70 tran- 
scripts. Total cellular RNAs derived 
from the patient's (Pt)or the con- 
trol's (C) HTLV-l-transformed 
thymocyte line were assessed by 
Northern blot analysis for ZAP-70 
or [3-actin transcripts. 
70 gene is in progress but preliminary Southern blot analy- 
sis has failed to reveal gross deletions in the ZAP-70 gene 
(data not shown). Collectively, these studies suggest hat 
the TCR on CD4 + peripheral T cells from this patient fail 
to signal because of  the absence of ZAP-70 transcripts and 
protein. 
The TCR on the Patient's Thymocyte Line Is Competent to 
Mediate Signal Transduction Events. In an effort o further 
understand the molecular basis for the differential signal 
transduction capability of  the TCR on the patient's thy- 
mocytes and peripheral T cells, the signal transduction 
function of  the TCR on the HTLV-l-transformed thy- 
mocyte line was analyzed by examining changes in [Ca2+]i . 
The control and patient lines were rested for 16 h in the 
absence of exogenous IL-2 before stimulation of  the TCR 
with anti-CD3 mAb. Similar to the response of the TCRs 
on thymocytes from the patient's biopsy (Fig. 2 D), the 
TCR on the patient's HTLV-l-transformed thymocyte 
line responded to anti-CD3 mAbs, with increases in 
[Ca2+]i (Fig. 5 B), although somewhat delayed when com- 
pared to those of  the control thymocyte (Fig. 5 A). The pa- 
tient's thymocyte line thus appears to express a TCR 
which, like the freshly isolated thymocytes from this pa- 
tient, is able to induce a signal transduction event charac- 
teristic of  the TCR on normal T cells and thymocytes. 
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Figure 5. The TCR on the patient's HTLV-l-transformed thymocyte 
line can induce increases in [Ca2+] i  . Indo-l-loaded control (A) or patient 
(B) HTLV-l-transformed thymocyte lineswere stimulated with biotiny- 
lated anti-CD3 mAb (Leu4-B) followed by streptavidin (A) as indicated. 
Changes in [Ca2+]i were monitored by fluorimetry. 
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Induction of Tyrosine Phosphoproteins after Stimulation of the 
TCR on the Thymic Line. Because of the limited patient 
material available, signal transduction function of the TCR 
was studied in more detail with the available HTLV-1- 
transformed thymocyte line. Since previous reports of 
ZAP-70-deficient peripheral T cells demonstrated a failure 
of these cells to mediate an increase in the tyrosine phos- 
phorylation of several cellular substrates, including PLC~I 
(7, 9), we examined whole-cell ysates from control and 
patient HTLV-l-transformed thymocyte lines after stimu- 
lation with anti-CD3 mAb. Similar to the rapid induction 
of tyrosine phosphoproteins observed in the control thy- 
mocyte line, increases in tyrosine phosphoproteins could be 
observed after stimulation of the TCR on the patient hy- 
mocyte line (Fig. 6 A). Virtually identical results were ob- 
tained regardless of whether the TCR was cross-linked 
with anti-CD3 mAb alone or after co-cross-linking with a 
combination of anti-CD4 and anti-CD3 mAbs (data not 
shown). Interestingly, the pattern of tyrosine phosphopro- 
teins in the patient's thymocyte line differed from the con- 
trol thymocyte line. Notably, prominent 70- and 72-kD 
tyrosine phosphoproteins were observed in the control 
line, while only a 72-kD tyrosine phosphoprotein was 
abundant in the patient line. In addition, a protein migrat- 
ing at ~24 kD was observed in the control ine but not in 
the patient line. This phosphoprotein may represent a TCR-~ 
chain and/or CD3 components ( ee below). These results 
suggest that the TCR in the patient thymocyte line is able 
to couple to cytoplasmic PTKs. 
Induction oftyrosine phosphoproteins after TCR stimu- 
lation of the patient's thymocyte line was somewhat sur- 
prising since previous studies of the TCR in peripheral 
blood T cell from patients with ZAP-70 deficiency had 
Figure 6. Stimulation of the TCR on the patient's thymocyte line in- 
duces increases in cellular tyrosine phosphoproteins including Syk. (A) 
Whole-cell ysates from the control thymocyte line (C) or from the pa- 
tient's thymocyte line (Pt) were prepared before ( - )  or after stimulation 
with biotinylated anti-CD3 mAb and streptavidin (+) and blotted with 
an antiphosphotyrosine mAb. (B) Syk (lanes 5-8) or ZAP-70 (lanes 9-12) 
immunoprecipitates were isolated using rabbit heterosera from the lines 
before or after stimulation and blotted with an antiphosphotyrosine mAb. 
(C) TCR-{ immunoprecipitates (lanes 13-16), isolated from control and 
patient lines before and after stimulation using an anti-TCR-~ heterose- 
ram, were probed with an antiphosphotyrosine mAb. Note that the band 
running below ZAP-70 in lane 10 likely represents Lck, since Lck and 
ZAP have been shown to coprecipitate with the { chain. 
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shown a relative failure to induce tyrosine phosphoproteins 
after receptor stimulation (7-9). The ability of the patient's 
thymocytes and the HTLV-l-transformed thymic line to 
signal in the absence of ZAP-70, was further assessed by 
immunoprecipitation f Syk, ZAP-70, and the ~ chain 
from the control and patient hymic lines before and after 
TCR stimulation. Stimulation of the TCR in the control 
line resulted in the induction of prominent tyrosine phos- 
phorylation of ZAP-70, as well as the ~ chain (Fig. 6, lanes 
10 and 14), but relatively minimal induction of Syk ty- 
rosine phosphorylation (Fig. 6, lane 6). ZAP-70 immuno- 
precipitates from the control ine contained only low levels 
oftyrosine-phosphorylated ~ chain in the basal state (Fig. 6, 
lane 9) but an increased level from stimulated cells (Fig. 6, 
lane 10). In marked contrast, no tyrosine phosphorylation 
of the ~ chain was observed in Syk immunoprecipitates, 
despite the modest induction of tyrosine phosphorylation 
of Syk in the control ine. Prolonged exposures of this blot 
failed to demonstrate an association between Syk and the 
chain or CD3 chains in the control ine. Thus, in the con- 
trol line, there was a marked increase in the tyrosine phos- 
phorylation of ~ and ZAP-70 but only a modest increase in 
Syk phosphorylation. No association between Syk and 
was observed after TCR stimulation. 
In contrast o the response in the control ine, Syk was 
more highly phosphorylated after TCR stimulation of the 
patient hymocyte line (Fig. 6, lane 8). These findings sug- 
gest that Syk undergoes very prominent phosphorylation in 
the absence of ZAP-70. In part, this could reflect the 
higher levels of Syk expression in the patient line (Fig. 3 
B). Despite this marked degree of tyrosine phosphorylation 
of Syk, no associated ~chain was coimmunoprecipitated 
with Syk, nor was the ~ chain detectably t rosine phosphor- 
ylated in the patient line (Fig. 6, lanes 8 and I6). Thus, Syk 
does not appear to form a stable complex with ~, nor could 
we detect the induced tyrosine phosphorylation of ~. In 
other experiments, we were also unable to detect yrosine 
phosphorylation f the CD3 chains (including CD3{) in the 
patient line after TCR stimulation (data not shown). 
Moreover, we were unable to detect he FcR~/chain in ly- 
sates of the thymic cell line by immunoblotting (in contrast 
to a rat basophilic leukemia cell line as a control, data not 
shown), eliminating the possibility of Syk association with 
the TCR via phosphorylated FcR% These findings suggest 
that Syk can couple to the TCR signaling pathway in the 
absence of ZAP-70, though its interaction with the TCR 
may differ qualitatively or quantitatively. 
Discussion 
At least four cytoplasmic PTKs have been shown to in- 
teract with the TCR and to contribute to its signal trans- 
duction function: Fyn, Lck, ZAP-70, and Syk. The conse- 
quences of mutations in three of these PTKs have resulted 
in rather distinct phenotypes in mice whose genes have 
been purposefully disrupted, or in humans whose disease 
results from inherited mutations. The resultant phenotypic 
abnormalities provide unique insights into the role of  TCR 
signal transduction and these PTKs in TCR function and 
in T cell development. 
In mice lackingfyn as a result of  gene disruption, general 
features of  T cell subset maturation are not altered and the 
numbers o fT  cells in the thymus, and peripheral lymphoid 
organs are preserved (16, 17). The loss of  Fyn has the great- 
est impact in TC1L signal transduction function within the 
most mature single positive (CD4 + or CD8 +) subsets of  
thymocytes, whereas the signal transduction function of  
TCRs  on peripheral T cells appears to be restored to a large 
extent (16, 17). There is an impairment in signal transduc- 
tion through the GPI-linked molecule Thy-1 (17). These 
observations suggest hat the function of  Fyn in TCR sig- 
naling may be most important in a developmentally re- 
stricted compartment or in signal transduction via receptors 
other than the TCR.  
In contrast o fyn, disruption of  the lck gene results in a 
severe arrest of  thymocyte development a a very immature 
stage, the transition from double negative (CD4- /CD8- )  
to double positive (CD4+/CD8 +) thymocytes (20). A 
small number of  T cells are found in the peripheral lym- 
phoid tissues. Whether this occurs via compensatory up- 
regulation of  other PTKs was not examined. The few pe- 
ripheral T cells that do develop and populate peripheral 
lymphoid organs also exhibit diminished responses to typi- 
cal TCR stimuli, suggesting an impairment in TCR signal 
transduction function. This is consistent with the loss of 
TC1L signal transduction function in a Jurkat-derived T
cell mutant line and in a cytolytic T cell clone that were 
found to be deficient in Lck kinase expression (18, 19). Lck 
also appears to play a role in allelic exclusion of  the TC1L-[3 
chain (35). These observations uggest that Lck plays a 
prominent role in TC1L signal transduction and contributes 
to developmental decisions early during thymic ontogeny. 
In humans, mutations in the ZAP-70 gene that impair 
expression or function give rise to a phenotype that is 
clearly distinct from the deletions offyn or lck. The periph- 
eral blood and thymus are deficient in CD8 + T cells, and 
circulating CD4 + T cells fail to signal appropriately through 
the TCR.  There is a failure of  protein tyrosine phosphory- 
lation and the mobilization of  [Ca2+]i after TC1L stimula- 
tion, suggesting that ZAP-70 is essential for TCR-medi -  
ated signaling in CD4 + cells. Moreover, it would appear 
that redundant pathways or compensatory changes in the 
functions of  other PTKs are not present or certainly not 
detectable in the ZAP-70-deficient peripheral CD4 + T 
cells. Since there are abundant numbers of  double positive 
(cortical) and CD4 + (medullary) thymocytes with a paucity 
of  CD8 + (medullary) thymocytes, this also implies that 
ZAP-70 may not be essential for the transition of  double- 
positive CD4+/CD8 + thymocytes to single positive CD4 + 
Figure 7. Scheme for T cell selection i the absence ofZAP-70. ZAP-70 may be indispensable formaturation i to CD8 + T cells but not CD4 + T cells. 
For CD4 + T cell selection i the thymus, Syk may be capable of compensating for the loss of ZAP-70. In addition, the differential level of association uf
Lck with CD4 and CD8 is shown. 
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T cells. Based on the phenotype of the ZAP-70-deficient 
patients, it appears that ZAP-70 may be indispensable for 
maturation into CD8 + T cells, but not CD4 + T cells (see 
model in Fig. 7). 
The homologous 72-kD PTK Syk may also play a role 
in TCP,. signal transduction. As observed for the stimula- 
tion of ZAP-70, TCP, stimulation results in the tyrosine 
phosphorylation of Syk and the association of phosphory- 
lated ~ with Syk in the Jurkat T lymphoblastoid cell line 
and in a heterologous Cos cell expression system (22). 
Moreover, chimeras in which Syk has been fused to an- 
other transmembrane receptor can initiate signal transduc- 
tion events imilar to those induced by the stimulated TCP, 
(36). Thus, Syk may play a role in TCP, signal transduction 
that is similar, though perhaps not identical to that of ZAP- 
70. In the thymus, where expression of Syk is highest in 
the T cell lineage (22), Syk may be capable of compensat- 
ing for the loss of ZAP-70. This may account for the ability 
of the TCR on thymocytes in ZAP-70-deficient individu- 
als to mediate signal transduction events. This could, in 
turn, permit the CD4 + lineage cells to be positively se- 
lected and circulate in the peripheral blood (Fig. 7). 
The evidence that Syk is coupled to the TCP, and can 
compensate for the loss of ZAP-70 in the thymus of these 
patients is supported by our observations of the patient's 
HTLV-l-transformed thymocyte line which, like the fresh 
thymocytes from this patient, signaled through the TCR.. 
This suggests that the TCP, in this line is coupled to cyto- 
plasmic PTKs. After TCR stimulation, Syk was rapidly ty- 
rosine phosphorylated in this ZAP-70-deficient cell. This 
also occurred in the control thymocyte cell line, but not to 
the same extent. The smaller degree oftyrosine phosphory- 
lation of Syk in the control line could reflect its competi- 
tion with ZAP-70 for interaction with the TCP,. Alterna- 
tively, it could reflect the lower levels of Syk expression in 
the ZAP-70-positive control line. The higher level of ex- 
pression of Syk in the ZAP-70-deficient cells might repre- 
sent a compensatory mechanism in response to ZAP-70 
loss. Unfortunately, this could not be confirmed with fresh 
ZAP-70-deficient thymocytes from this patient since they 
were not available for analysis. The HTLV-l-transformed 
thymocyte cell line from the patient resembled his thy- 
mocytes in that the levels of Syk were higher than in pe- 
ripheral T cells. The downregulation of Syk expression that 
occurs in peripheral T cells, as has been described in normal 
humans and mice, could account for the loss of TCR signal 
transduction function in the peripheral blood CD4 + T cells 
in ZAP-70--deficient patients. 
If Syk compensates for the loss of ZAP-70 in the thy- 
mus, the failure of Syk to participate in the positive selec- 
tion of CD8 + cells must be explained. One possibihty is 
that differentiation towards the CD4 rather than the CD8 
lineage reflects the involvement of a more efficient signal 
transduction mechanism. If Syk is unable to fully replace 
the function of ZAP-70, signal transduction by the TCR. 
in the thymus might be partially compromised. Since Lck 
has a greater association with CD4 than CD8 in double- 
positive thymocytes, this may contribute to a preferential 
selection of the CD4 lineage (37). Thus, signal transduction 
by the TCR in ZAP-70-deficient thymocytes may only 
reach an appropriate threshold in the events leading to 
CD4 but not CD8 lineage selection. 
An unexpected finding in these studies was the failure to 
detect tyrosine-phosphorylated Syk associated with ~ or 
CD3 after TCP, stimulation in either of the HTLV- I  thy- 
mocyte lines. We also failed to detect any phosphorylated 
or CD3 chains in the ZAP-70--deficient line after TCP, 
stimulation despite the inducible tyrosine phosphorylation 
of Syk and other proteins. It is possible that the interaction 
of Syk with the TCR is a transient event in these HTLV-1 
lines. Alternatively, these lines might express regulatory 
proteins that cause a rapid dissociation of the SH2 domains 
of Syk from the phosphorylated tyrosine residues contained 
in the activation motifs present in the ~ and CD3 chains. 
Another possibility is raised by the studies of Couture et ai. 
(31), who suggested that Syk might function upstream of 
Lck and ZAP-70. Syk levels, however, are very tow in pe- 
ripheral T cells where signaling does not appear to occur in 
the absence of ZAP-70, and we have not been able to re- 
produce their findings (data not shown). 
Our studies provide insights into mechanisms that may 
explain the paradoxical phenotype of peripheral T cells in 
ZAP-70-deficient patients. The ability of the TC1L to dif- 
ferentially signal in the thymus but not in peripheral CD4 + 
ceils offers an explanation for how CD4 + cells are selected. 
Our results uggest that in the absence ofZAP-70, Syk may 
play a compensatory ole in regulating this positive selec- 
tion (Fig. 7). The preferential selection of CD4 + cells may 
reflect an increased association of Lck with CD4 rather 
than CD8. Thus, in a cell with a compromised TCP, sig- 
naling pathway because of ZAP-70 deficiency, only the se- 
lection events that involve CD4 coreceptors may yield fig- 
nals of sufficient magnitude for further differentiation i to 
more mature cells. The absence of single positive CD8 cells 
in the thymus of these patients upports the notion that 
positive selection occurs at the transition of double-positive 
to single-positive cells. Downregulation of Syk during de- 
velopment and/or the absolute requirement for ZAP-70 
may explain why peripheral CD4 + T cells lacking ZAP-70 
do not have signal competent TCRs. 
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